Thrombin formation and platelet activation at the site of vascular injury in patients with coronary artery disease treated with clopidogrel combined with aspirin

Kardiologia Polska

Volumn 67, Issue 6, 2009, Pages 591-598

  Undas, Anetta ^a   Stȩpień, Ewa ^b   Branicka, Agnieszka ^b   Wołkow, Paweł ^a   Zmudka, Krzysztof ^a   Tracz, Wiesława ^a  

^a JAGIELLONIAN UNIVERSITY MEDICAL COLLEGE   (Poland)

^b Krakowski Szpital Specjalistyczny Im Jana Pawła II   (Poland)

Author keywords

Aspirin; Clopidogrel; Coronary artery disease; Platelets; Thrombin; Vascular injury

Indexed keywords

ACETYLSALICYLIC ACID; ASPIRIN PROTECT; CD40 LIGAND; CLOPIDOGREL; GLYCOPROTEIN IIIA; PADGEM PROTEIN; PROTHROMBIN; THROMBIN; THROMBIN ANTITHROMBIN COMPLEX; THROMBOXANE B2; UNCLASSIFIED DRUG;

ADD ON THERAPY; ADULT; AGED; ALLELE; ANTICOAGULANT THERAPY; ARTICLE; BLEEDING TIME; BLOOD VESSEL INJURY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY DISEASE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; OPEN STUDY; PROTEIN EXPRESSION; RANDOMIZED CONTROLLED TRIAL; THROMBOCYTE ACTIVATION; THROMBOGENESIS;

EID: 67649663703     PISSN: 00229032     EISSN: 00229032     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Undas A, Brummel-Ziedins KE, Mann KG. Antithrombotic properties of aspirin and resistance to aspirin: beyond strictly antiplatelet actions. Blood 2007; 109: 2285-2292 (Pubitemid 46425865)
2. Monroe DM, Hoffman M, Roberts HR. Platelets and thrombin generation. Arterioscler Thromb Vasc Biol 2002; 22: 1381-1389 (Pubitemid 35050717)
3. Eshaghion S, Kaul S, Amin S, et al. Role of clopidogrel in managing atherothrombotic cardiovascular disease. Ann Intern Med 2007; 146: 434-441 (Pubitemid 351650580)
4. Eikelboom JW, Weitz JI, Budaj A, et al. for the Clopidogrel in Unstable angina to prevent Recurrent Events (CURE) Study Investigators. Clopidogrel does not suppress blood markers of coagulation activation in aspirin-treated patients with non-ST-elevation acute coronary syndromes. Eur Heart J 2002; 23: 1771-1779
5. Müller I, Massberg S, Zierhut W, et al. Effects of aspirin and clopidogrel versus oral anticoagulation on platelet function and on coagulation in patients with nonvalvular atrial fibrillation (CLAFIB). Pathophysiol Haemost Thromb 2002; 32: 16-24. (Pubitemid 37490483)
6. Cassar K, Bachoo P, Ford I, et al. Clopidogrel has no effect on D-dimer and thrombin-antithrombin III levels in patients with peripheral arterial disease undergoing peripheral percutaneous transluminal angioplasty. J Vasc Surg 2005; 42: 252-258 (Pubitemid 41139230)
7. Azar RR, Kassab R, Zoghbi A, et al. Effects of clopidogrel on soluble CD40 ligand and on high-sensitivity C-reactive protein in patients with stable coronary artery disease. Am Heart J 2006; 151: 521.e1-4 (Pubitemid 43144760)
8. Stellbaum C, Willich T, Boltzen U, et al. Clopidogrel-mediated reduction of circulating tissue factor in patients with stable coronary artery disease. Eur J Haematol 2007; 78: 347-352 (Pubitemid 46365084)
9. Welterman A, Fritsch P, Kyrle PA, et al. Effects of pretreatment with clopidogrel on platelet and coagulation activation in patients undergoing elective coronary stenting. Thromb Res 2003; 112: 19-24.
10. Quinn MJ, Bhatt DL, Zidar F, et al. Effect of clopidogrel pretreatment on inflammatory marker expression in patients undergoing percutaneous coronary intervention. Am J Cardiol 2004; 93: 679-684 (Pubitemid 38338553)
11. Xiao Z, Theroux P. Clopidogrel inhibits platelet-leukocyte interactions and thrombin receptor agonist peptide-induced platelet activation in patients with an acute coronary syndrome. J Am Coll Cardiol 2004; 43: 1982-1988 (Pubitemid 38686790)
12. Weiss HJ, Lages B. Evidence for tissue factor-dependent activation of the classic extrinsic coagulation mechanism in blood obtained from bleeding time wounds. Blood 1988; 71: 629-635 (Pubitemid 18102079)
13. Undas A, Brummel KE, Musial J, et al. Simvastatin depresses blood clotting by inhibiting activation of prothrombin, factor V, and factor XIII and by enhancing factor Va inactivation. Circulation 2001; 103: 2248-2253 (Pubitemid 32433713)
14. Undas A, Stȩpień E, Nizankowski R, et al. Effects of simvastatin on angiogenic growth factors released at the site of microvascular injury. Thromb Haemost 2006; 96: 342-347
15. Dropinski J, Musial J, Jakiela B, et al. Anti-thrombotic action of clopidogrel and Pl (A1/A2) polymorphism of beta3 integrin in patients with coronary artery disease not being treated with aspirin. Thromb Haemost 2005; 94: 1300-1305 (Pubitemid 41819630)
16. Undas A, Brummel K, Musial J, et al. Blood coagulation at the site of microvascular injury: effects of low-dose aspirin. Blood 2001; 98: 2423-2431
17. Undas A, Brummel K, Musial J, et al. PlA2 polymorphism of b3 integrins is associated with enhanced thrombin generation and impaired antithrombotic action of aspirin at the site of microvascular injury. Circulation 2001; 104: 2666-2672 (Pubitemid 33108131)
18. Aukrust P, Damas JK, Solum NO. Soluble CD40L and platelets: self-perpetuating pathogenic loop in thrombosis and inflammation? J Am Coll Cardiol 2004; 43: 2326-2328
19. Serebruany VL, Malinin AI, Atar D, et al. Consistent platelet inhibition during long-term maintenance-dose clopidogrel therapy among 359 compliant outpatients with documented vascular disease. Am Heart J 2007; 153: 371-377 (Pubitemid 46328764)
20. Payne DA, Hayes PD, Jones CI, et al. Combined therapy with clopidogrel and aspirin significantly increases the bleeding time through a synergistic antiplatelet action. J Vasc Surg 2002; 35: 1204-1209 (Pubitemid 44718523)
21. Serebruany VL, Steinhubl SR, Berger PB, et al. Variability in platelet responsiveness to clopidogrel among 544 individuals. J Am Coll Cardiol 2005; 45: 246-251 (Pubitemid 40094733)
22. Gurbel PA, Blinden KP, Hiatt BL, et al. Clopidogrel for coronary stenting: response variability, drug resistance, and the effect of pretreatment platelet reactivity. Circulation 2003; 107: 2908-2913 (Pubitemid 36736631)
23. Lev EI, Patel RT, Guthikonda S, et al. Genetic polymorphisms of the platelet receptors P2Y (12), P2Y (1) and GPIIIa and response to aspirin and clopidogrel. Thromb Res 2007; 119: 355-369
24. Gurbel PA, Bliden KP, Guyer K, et al. Delayed thrombin-induced platelet-fibrin clot generation by clopidogrel: a new dose-related effect demonstrated by thrombelastography in patients undergoing coronary artery stenting. Thromb Res 2007; 119: 563-570 (Pubitemid 46321504)